Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GSK

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy compa...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKline

Text size AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy company Sierra Oncology for $1.9 billion in cash, as it looks to boost its portfolio of new specialty medicine...